A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic ...

An initiative at a cancer center encouraged nurses to “Have a Seat” while performing some nursing care improved patient perceptions of the care they received.

A team of US researchers has found a new drug delivery system that showed more efficacy and improved the treatment of a rare ...

The Childhood Eye Cancer Trust (CHECT) highlights signs such as a white glow in the eye, squint, changes in eye colour, or ...

A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic delivery system may ...

A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic delivery system may help patients with a rare eye cancer that has spread to ...

Benefits advisors need to stay proactive and help their clients leverage formulary design, clinical oversight, and ...

Krystal Biotech's shares have dropped 22% since July 2024 due to competition concerns. Read more to see a full investment ...